Biotech Values

[biophud]

Dew--an interesting article on CYTX. In general, I am skeptical on stem cell stocks, at least for the short term. I think the science is promising but I think that it is too soon for investing in stem cell biotechs. Am I wrong? Are there any stem cell biotechs that you regard as investment grade?

On thing I like about CYTX's approach is that it uses an ex-vivo stem cell expansion and then reimplants the cells into the patient-thus mitigating the possibility for immune rejection.

Another strategy I like is that of stem cell mobilization (Anormed which was acquired by GENZ). I think that this approach is a more conservative strategy (relative to cellular-based therapies) and is more likely to be adopted, in the near future.

Comments appreciated,

biophud